Clinical Trials Browser

Terminated × Has results × MEDI2070 × Clear all

NCT02574637 2021-05-26

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Phase 2 Terminated

29 enrolled 25 charts

Crohn Disease, Inflammatory Bowel Diseases